Beyond Mismatch: Evolving Paradigms in Imaging the Ischemic Penumbra With Multimodal Magnetic Resonance Imaging

Stroke

Volumn 34, Issue 11, 2003, Pages 2729-2735

  Kidwell, Chelsea S ^a,b,c   Alger, Jeffry R ^a   Saver, Jeffrey L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ischemia; Magnetic resonance imaging, diffusion weighted; Magnetic resonance imaging, perfusion weighted; Penumbra

Indexed keywords

BRAIN ISCHEMIA; BRAIN PERFUSION; DIFFUSION WEIGHTED IMAGING; EARLY DIAGNOSIS; HUMAN; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECANALIZATION; REVIEW; STROKE;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION;

EID: 0242694042     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000097608.38779.CC     Document Type: Review

References (51)

1. NINDS rt-PA Stroke Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Hakim AM. The cerebral ischemic penumbra. Can J Neurol Sci. 1987;14:557-559.
3. Baron J. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis. 1999;9:193-201.
4. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol. 1994;36:557-565.
5. Ginsberg MD, Pulsinelli WA. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke. Ann Neurol. 1994:36:553-554.
6. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab. 1998;18:583-609.
7. Schlaug G, Benfield A, Baird AE, et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology. 1999;53:1528-1537.
8. Baird AE, Benfield A, Schlaug G, et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol. 1997;41:581-589.
9. Warach S, Pettigrew LC, Dashe JF, et al, for the Citicoline 010 Investigators. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Ann Neurol. 2000;48:713-722.
10. Warach S, Hacke W, Hsu C, et al. Effect of MaxiPOST on ischemic lesions in patients with acute stroke: the POST-010 MRI substudy. Stroke. 2002;33:383. Abstract.
11. Jansen O, Schellinger P, Fiebach J, et al. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet. 1999;353:2036-2037.
12. Parsons MW, Barber PA, Chalk J, et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol. 2002;51:28-37.
13. Ostrem JL, Kidwell CS, Saver JL, et al. Basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial thrombolysis. Stroke. 2002;33:360.
14. Darby DG, Barber PA, Gerraty RP, et al. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke. 1999;30:2043-2052.
15. Marchal G, Beaudouin V, Rioux P, et al. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke. 1996;27:599-606.
16. Heiss WD, Huber M, Fink GR, et al. Progressive derangement of peri-infarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab. 1992;12:193-203.
17. Astrup J, Symon L, Branston NM, Lassen N. Thresholds of cerebral ischemia. In: Schmiedek P, ed. Microsurgery for Stroke. Berlin, Germany: Springer; 1976:16-21.
18. Grandin CB, Duprez TP, Smith AM, et al. Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology. 2002;223:361-370.
19. Neumann-Haefelin T, Wittsack HJ, Wenserski F, et al. Diffusion- and perfusion-weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke. 1999;30:1591-1597.
20. Thijs VN, Adami A, Neumann-Haefelin T, et al. Relationship between severity of MR perfusion deficit and DWI lesion evolution. Neurology. 2001;57:1205-1211.
21. Rohl L, Ostergaard L, Simonsen CZ, et al. Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient. Stroke. 2001;32:1140-1146.
22. Parsons MW, Yang Q, Barber PA, et al. Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke. 2001;32:1581-1587.
23. Desmond PM, Lovell AC, Rawlinson AA, et al. The value of apparent diffusion coefficient maps in early cerebral ischemia. AJNR Am J Neuroradiol. 2001;22:1260-1267.
24. Oppenheim C, Grandin C, Samson Y, et al. Is there an apparent diffusion coefficient threshold in predicting tissue viability in hyperacute stroke? Stroke. 2001;32:2486-2491.
25. Fiehler J, Knab R, Reichenbach JR, et al. Apparent diffusion coefficient decreases and magnetic resonance imaging perfusion parameters are associated in ischemic tissue of acute stroke patients. J Cereb Blood Flow Metab. 2001;21:577-584.
26. Warach S. Tissue viability thresholds in acute stroke: the 4-factor model. Stroke. 2001;32:2460-2461.
27. Wu O, Koroshetz WJ, Ostergaard L, et al. Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging. Stroke. 2001;32:933-942.
28. Jacobs MA, Mitsias P, Soltanian-Zadeh H, et al. Multiparametric MRI tissue characterization in clinical stroke with correlation to clinical outcome: part 2. Stroke. 2001;32:950-957.
29. Dijkhuizen RM, Berkelbach van der Sprenkel JW, Tulleken KA, Nicolay K. Regional assessment of tissue oxygenation and the temporal evolution of hemodynamic parameters and water diffusion during acute focal ischemia in rat brain. Brain Res. 1997;750:161-170.
30. Mintorovitch J, Moseley ME, Chileuitt L, et al. Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med. 1991;18:39-50.
31. Hossmann KA, Fischer M, Bockhorst K, Hoehn-Berlage M. NMR imaging of the apparent diffusion coefficient (ADC) for the evaluation of metabolic suppression and recovery after prolonged cerebral ischemia. J Cereb Blood Flow Metab. 1994;14:723-731.
32. Hasegawa Y, Fisher M, Latour LL, et al. MRI diffusion mapping of reversible and irreversible ischemic injury in focal brain ischemia. Neurology. 1994;44:1484-1490.
33. Minematsu K, Li L, Sotak CH, et al. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke. 1992;23:1304-1310.
34. Kidwell CS, Saver JL, Mattiello J, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000;47:462-469.
35. Lutsep HL, Nesbit GM, Berger RM, Coshow WR. Does reversal of ischemia on diffusion-weighted imaging reflect higher apparent diffusion coefficient values? J Neuroimaging. 2001;11:313-316.
36. Uno M, Harada M, Okada T, Nagahiro S. Diffusion-weighted and perfusion-weighted magnetic resonance imaging to monitor acute intraarterial thrombolysis. J Stroke Cerebrovasc Dis. 2000;9:113-120.
37. Fiehler J, Foth M, Kucinski T, et al. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke. 2002;33:79-86.
38. Chalela JA, Ezzeddine MA, Callabrese TM, et al. Diffusion and perfusion changes two hours after intravenous rt-PA therapy: a preliminary report. Stroke. 2002;33:356-357.
39. Kidwell CS, Saver JL, Starkman S, et al. Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol. 2002;52:698-703.
40. Latour LL, Warach S. Cerebral spinal fluid contamination of the measurement of the apparent diffusion coefficient of water in acute stroke. Magn Reson Med. 2002;48:478-486.
41. Kidwell CS, Alger JR, Saver JL, et al. MR signatures of infarction vs salvageable penumbra in acute human stroke: a preliminary model. Stroke. 2000;31:285.
42. Sunshine JL, Tarr RW, Lanzieri CF, et al. Hyperacute stroke: ultrafast MR imaging to triage patients prior to therapy. Radiology. 1999;212:325-332.
43. Selim M, Fink JN, Kumar S, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke. 2002;33:2047-2052.
44. Warach S, Rodriguez SU, Olan WJ. Routine screening for IV tPA therapy less than 3 hours with MRI: initial clinical experience. Stroke. 2001;32:371.
45. Liebeskind DS, Yang CK, Sayre J, Bakshi R. Neuroimaging of cerebral ischemia in clinical practice. Stroke. 2003;34:255. Abstract.
46. Kidwell CS, Chalela JA, Saver JL, et al. Hemorrhage Early MRI Evaluation (HEME) study: preliminary results of a multicenter trial of neuroimaging in patients with acute stroke symptoms within 6 hours of onset. Stroke. 2003;34:239. Abstract.
47. Schellinger PD, Fiebach JB, Gass A, et al. Accuracy of stroke MRI in hyperacute intracerebral hemorrhage <6 hours: a prospective standardized blinded multicenter study. Stroke. 2003;34:239.
48. Lee JM, Vo KD, An H, et al. Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients. Ann Neurol. 2003;53:227-232.
49. Parsons MW, Li T, Barber PA, et al. Combined (1)H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology. 2000;55:498-505.
50. Ostergaard L, Sorensen AG, Chesler DA, et al. Combined diffusion-weighted and perfusion-weighted flow heterogeneity magnetic resonance imaging in acute stroke. Stroke. 2000;31:1097-1103.
51. Rother J, Schellinger PD, Gass A, et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke. 2002;33:2438-2445.